Energy, Sexual Desire and Body PropoRtions wIth AndroGel, Testosterone 1% Gel Therapy (ESPRIT) in Hypogonadal Men.
Phase of Trial: Phase IV
Latest Information Update: 23 Sep 2011
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- Acronyms ESPRIT
- Sponsors Abbott Laboratories
- 27 Jul 2011 Additional trial locations Croatia, Kuwait, Russia, Saudi Arabia, United Arab Emirates identified as reported by ClinicalTrials.gov.
- 17 Nov 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 17 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.